Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea

Infection

Volumn 42, Issue 5, 2014, Pages 875-881

  Lim, S J ^a   Choi, J Y ^a   Lee, S J ^a,b   Cho, Y J ^a,b   Jeong, Y Y ^a,b   Kim, H C ^a,b   Lee, J D ^a,b   Hwang, Y S ^a,b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Acquired; Blood stream infection; Cause; ICU

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

AGED; BACTEREMIA; BACTERIUM; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; FUNGEMIA; FUNGUS; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER;

AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTEREMIA; BACTERIA; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; FUNGEMIA; FUNGI; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS;

EID: 84918797406     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0651-z     Document Type: Article

References (30)

1. Barsanti MC, Woeltje KF. Infection prevention in the intensive care unit. Infect Dis Clin North Am. 2009;23:703–25.
2. Donowitz LG, Wenzel RP, Hoyt JW. High risk of hospital-acquired infection in the ICU patient. Crit Care Med. 1982;10:355–7.
3. Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 1991;91:179S–84S.
4. Wenzel RP, Thompson RL, Landry SM, Russell BS, Miller PJ, Ponce de Leon S, et al. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control. 1983;4:371–5.
5. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–17.
6. Arya SC, Agarwal N. Nosocomial infections in adult intensive-care units. Lancet. 2003;362:493–4.
7. Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis. 1997;24:387–95.
8. Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis. 2006;42:1118–26.
9. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 2001;163:1584–90.
10. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.
11. Kim JM, Park ES, Jeong JS, Kim KM, Oh HS, Yoon SW, et al. Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection Control. Am J Infect Control. 2000;28:454–8.
12. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976–81.
13. Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011;15:R100.
14. Kwak YG, Cho YK, Kim JY, Lee SO, Kim HY, Kim YK, et al. Korean Nosocomial Infections Surveillance System, Intensive Care Unit Module Report: data Summary from July 2008 through June 2009 and Analysis of 3-Year Results. Korean J Nosocomial Infect Control. 2010;15:14–25.
15. Pai H. Nosocomial infections in intensive care unit: epidemiology and control strategy. Hanyang Med Rev. 2011;31:153–8.
16. Park ES, Jin HY, Jeong SY, Kweon OM, Yoo SY, Park SY, et al. Healthcare-associated infection surveillance in small and medium sized hospitals. Korean J Nosocomial Infect Control. 2011;16:54–62.
17. Jeon MH, Park WB, Kim SR, Chun HK, Han SH, Bang JH, et al. Korean Nosocomial Infections Surveillance System, Intensive Care Unit Module Report: data Summary from July 2010 through June 2011. Korean J Nosocomial Infect Control. 2012;17:28–39.
18. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–40.
19. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.
20. Ding JG, Sun QF, Li KC, Zheng MH, Miao XH, Ni W, et al. Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007. BMC Infect Dis. 2009;9:115.
21. Hong SK, Hong SB, Lim CM, Koh Y. The characteristics and prognostic factors of severe sepsis in patients who were admitted to a medical intensive care unit of a tertiary hospital. Korean J Crit Care Med. 2009;24:28–32.
22. Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect. 2004;58:137–45.
23. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Ruden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection. 2005;33:50–5.
24. Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX. Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J (Engl). 2012;125:226–9.
25. Marra AR, Camargo LF, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA, et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49:1866–71.
26. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.
27. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–55.
28. Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412–8.
29. Osmon S, Ward S. Fraser VJ, Kollef MH: hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest. 2004;125:607–16.
30. Sreeramoju P. Preventing healthcare-associated infections: beyond best practice. Am J Med Sci. 2013;345:239–44.